Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny, Radj Gervais, +54

The Lancet Oncology

OncologyStandard ChemotherapyRandomised Phase 3PathologyBronchial Neoplasm +6

Brief Report: Severe Sotorasib-Related Hepatotoxicity and Non-Liver Adverse Events Associated With Sequential Anti–Programmed Cell Death (Ligand)1 and Sotorasib Therapy in KRASG12C-Mutant Lung Cancer

Ali Chour, Julie Denis, Céline Mascaux, +27

Journal of Thoracic Oncology

MedicineLiver PhysiologyApoptosisPharmacologyBrief Report +9

Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study

Alexis B. Cortot, L. Gérinière, G. Robinet, +10

Annals of Oncology

Neuro-oncologyPhase Ii TrialRadiation TherapyMedicineWhole Brain Radiotherapy +7

Effectiveness and safety of nivolumab in the treatment of lung cancer patients in France: preliminary results from the real-world EVIDENS study

Fabrice Barlési, A. Dixmier, D. Debieuvre, +22

OncoImmunology

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies

Teresa Morán, Jia Wei, Manuel Cobo, +167

Annals of Oncology

OncologyMedicinePathologyBrca1-rap80 Expression CustomizationBiomarker-directed Randomized Trials +8

Lung cancer among women in France.

M Grivaux, Jean Luc Breton, P. Bombaron, +9

Lung Cancer

Tobacco ControlCancer EpidemiologyMedicineEpidemiology Of CancerSmoking Related Lung Disease +4

Two-year survival with nivolumab in previously treated advanced non–small-cell lung cancer: A real-world pooled analysis of patients from France, Germany, and Canada

D. Debieuvre, Rosalyn A. Juergens, Bernard Asselain, +22

Lung Cancer

Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer

P. Thomas, G. Robinet, S. Gouva, +8

Lung Cancer

MedicineBronchial NeoplasmCancer TreatmentOncologyRadiation Oncology +3

An open multicenter phase II trial of weekly docetaxel for advanced-stage non-small-cell lung cancer in elderly patients with significant comorbidity and/or poor performance status: The GFPC 02-02b study

H. Lecaer, Fabrice Barlési, G. Robinet, +7

Lung Cancer

Elderly PatientsGfpc 02-02B StudyMedicineAdvanced Lung DiseaseClinical Trials +6

82 Treatment of advanced and disseminated non small lung cancer (NSCLC) in elderly patients: Results of the MIC regimen

P.J. Souquet, P. Bombaron, J. Brunel-Crova, +1

Lung Cancer

Geriatric OncologySmall Lung CancerElderly PatientsAdvanced Lung DiseaseMedicine +8